Revista de Gastroenterología del Perú - Volumen 20, Nº1 2000

Referencia Bibliográfica

1. Vierlin JM Inmune disorders of the liver and bile duct. Gastroenterol Clin North Am 1992; 21: 427-449

2. Kaplan MM Primary biliary cirrhosis. N Engl J Med 1987; 316: 521-528

3. Hamlyn AN, Sherlock A. The epidemiology of primary biliary cirrhosis: a survey of mortality in England and wales. Gut 1974; 15: 473-9

4. Hamlyn AN, Macklon AF, James O. Primary biliary cirrhosis: geographical clustering and symptomatic onset seasonality. Gut 1983; 24: 940-5

5. Triger DR, Berg PA; Rodes J Epidemiology of primary biliary cirrhosis. Liver 1984; 4: 195-200

6. Lofgren J, Jarnerot G, Danielssan D, Hemdal I. Incidence and prevalence of primary biliary cirrhosis in a defined population in sweden. Scand J Gastroenterol 1985; 20: 647-50

7. Angulo P, Lindor KD. Primary biliary corrhosis and primary sclerosing cholangitis. Clinics in Liver Diseases. 1999; 3(3): 529-570.

8. Bach N, Schaffner F. Familial primary biliary cirrhosis. J Hepatol 1994; 20:698-701.

9. Gores GI, Moore SB, Fisher LD et al. Primary biliary cirrhosis: associations with major histocompatibility complex class II antigens. Gastroenterology 1986; 90:1278 (abstract).

10. Brunner G, Klinge OA. Cholangitis with antinuclear antibodies (inmunocholangitis) resembling chronic non-supurative destructive cholangitis. Deust Med Wodienschr 1987; 112:1454-1458.

11. Klein R Kloppel G Garbe W et al. Antimitocondrial antibody profiles determined at early stages of primary biliary cirrhosis diffrentiate between a benignand a progresive course of the disease: a retrospective analysis of 76 patients over 6-18 years. J Hepatol 1991; 12:21-27.

12. Kenny RP, Czaja AJ, Ludwing J, Dickson ER. Frecuency and significance of antimitocondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986; 31:705-711.

13. Berg PA, Wiedmann KA, Sayars T et al Serological classification of chronic cholestatic liver diseases by the use of two different types of antibodies. Lancet 1980; 2: 1329-1331.

14. Dickson ER , Fleming CR, Ludwing J. Primary biliary cirrhosis. In : Popper H. Schaffner F., eds Progress in Liver disease. Vol 6 New York: Gnine & Stratton. 1979; 487.

15. Christensen E, Crowe I, Doniach D et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology 1980; 78:236-46.

16. Sherlock S, Schevel PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med 1973; 289:674-8

17. Rolando N, Nieri A, Tsukuyama L, Figueroa R et al. Cirrosis biliar Primaria. Libro de resúmenes VIII Congreso Peruano de Gastroenterología 1982; 15.

18. Long RG, Schever PJ, Sherlock S Presentation and course of asymptomatic primary biliary cirrhosis. Gastroenterology 1977; 72:1204-7.

19. Shapiro JM, Smith H, Schaffner F Serum Bilirrubin: a prognostic factor in primary biliary cirrhosis. Gut 1979; 20: 137-140.

20. Sasaki H Inove K, Higuchi K et al Primary biliary cirrhosis in Japan: National Survey by the subcommitte on autoinmune hepatitis. Gastroenterol Jpn 1985; 20: 476-85.

21. Goudie RB, Macsween RNM, Golberg DM. Serological and histological diagnosis of primary biliary cirrhosis J Clin Pathol 1966; 19: 527-538.

22. Klastkin G, Kantor FS. Mitochondrial antibody in primary biliary cirrhosis and other diseases. An Intern Med 1972; 77:533-541.

23. Muñoz LE, Thomas HC, Schever PJ, Doniach D, Sherlock S. Is mithocondrial antibody diagnostic of primary biliary cirrhosis? Gut 1981; 22: 136-140.

24. Sherlock S. Primary biliary cirrhosis: clarifying the issues. Am J Med 1994; 96 (supply 1ª): 275-325.

25. Doniach D, Delharity J, lindquist Hj et al Mitochondrial and other tissue auto antibodies in patients with biological false positivereactions for syphilis. Clin Exp Inmunol 1970; 6:871-884.

26. Klein R, Maisch B, Kochsiek K, Berg PA Demostration of organ specific antibodies against heart mitochondria (anti AM7) in sera from patients with some forms of heart diseases. Clin Exp Inmonol 1984; 58: 283-292.

27. Bassendine MF, Yeaman SJ. Serological Markers of primary biliary cirrhosis: Diagnosis, prognosis and subset (editorial). Hepatology 1992; 15:545-547.

28. Manns M, Meyer Z, Buchenfeld KH. A mitochondral antigen-antibody system in cholestatic liver diseases detected by radioinmunoassay. Hepatology 1982; 281.

29. Lindenbor-futinos J, Baum H, Berg PA. Mitochondrial antobodies in Primary biliary cirrhosis: species and non species specific determinants of M2 antigen. Hepatology 1985; 5:763-777.

30. Garassini MA, Garassini ME. Enfermedad Autoinmune del higadoII. Cirrosis Biliar Primaria. Gen 1995;49:82-89.

31. Fritzler MJ, Valencia DW, Mccarty GA. Speckled pattern antibodies resembling anticentromere antibodies. Arthritis Rheum 1985;27:92-96.

32. Szostecki C, Krippner H, Penner E, Bautz FAS. Autoinmune sera recognise a 100 KD nuclear protein antigen (sp-100). Clin Exp Immunol 1987;68:108-116.

33. Evans J, Reuben A, Craft J. PBC 95K, a 95- kilodalton nuclear autoantigen in primary biliary cirrhosis. Arthritis Rheum. 1991;34:731-736.

34. Fusconi M, Cassani F,Govoni M et al Antinuclear antibodies of primary biliary cirrhosis recognise 78-92 KD and 96-100 KD proteins of nuclear bodies. Clin Exp Immunol. 1991; 83:291-297.

35. Saló J, Caballería Ll, Bruguera M, Pares A, Rodes J¿ Colangitis autoinmune o cirrosis biliar primaria sin anticuerpos antimitocondriales?. Gastroenterol Hepatol 1997; 20: 5-22.

36. INVERNIZZI P, CROSIGNANI A, BATTEZZATI P.M. et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and negative premary biliary cirrhosis. Hepatology 1997; 25: 1090-1095.

37. Goodman ZD, Mcnally PR, Davis DR, Ishak Kg. Autoinmune Cholangitis: A variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995; 40: 1232-1242.

38. Heathcote J. Autoinmune cholangitis (leading article) Gut 1997; 40:440-442.

39. ChiH-Yen Chen, Ching-Liang LU, Chang-Fang Chiu et al. Primary biliary cirrhosis associated with mixed type autoinmune hemolytic anemia and sicca syndrome: A case report and review of literature. Am J Gastroenterol 1997; 92:1547-1549.

40. ChazoUilleres O, Wendu MD; Serfatyl L et al. Primary biliary cirrhosis- Autoinmune Hepatitis Overlap Syndrome:clinical features and response to therapy. Hepatology 1998; 28: 296-301.

41. Poupon RE, Poupon R, Baukau B. VDCA- PBC. Study Group. Ursopdiol for the long term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330:1342-1347.

42. Lindor KD, Dickson ER, Balduswb et al. Ursodeoxycholic acid in the treatment of primary cirrhosis. Gastroenterology 1994;106:1284-1290.

43. Heathcote EJ, Cauch-Dudgk K, Walker V et al The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19: 1149-1156.

44. Combes B, Carithers RL, Madrey WC at al. A randomized double-blind placebo controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22:759-766.